SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- 111, Inc.
(NASDAQ: YI) ("111" or the "Company"), a leading integrated online
and offline healthcare platform, announced the release of the fifth
episode in its 111 Insight series. The title announced today,
The Impact of the Internet and Other New Technologies on the
Medical Industry, is hosted by Dr. Gang Yu, Co-Founder and
Executive Chairman of 111, Inc. Dr. Yu will moderate a discussion
with Dr. Xiaobin Wu, President of
BeiGene Ltd, and Dr. Darren Ji, CEO
of Elpiscience Biopharma, Ltd.
Tencent video:
https://v.qq.com/x/page/b3042i4640s.html
The Impact of the Internet and other New Technologies on the
Medical Industry will feature:
- Impact of Internet and other new technologies on the medical
industry
- How China is revolutionizing
access to medical care, which in some ways exceeds the US and other
countries
- Positive impact of the Internet on the medical industry
- Reduction of hospital operational pressures, and improvement of
efficiencies for doctors and chronic disease patients
- Improvement of the quality of healthcare services for patients in
rural areas
- How artificial intelligence plays a significant role in
healthcare and medical sector as a method of combining medical
resources and patient education
The 111 Insight series is produced by 111, Inc. and is hosted by
Dr. Gang Yu, Co-Founder and Executive Chairman, and Mr.
Junling Liu, Co-Founder, Chairman
and CEO. The series focuses on important topics in the global
healthcare industry and the state of the industry in China through interviews with industry
experts, investors, and healthcare professionals.
The healthcare industry in China is evolving rapidly and there is
increasing global interest in China's health reform and policies. Among the
topics that will be discussed throughout the series are: How the
Internet is reshaping China's
healthcare industry and pharmaceutical delivery market; how new
government policies and regulations are impacting the healthcare
industry; how new technologies are changing private health
insurance; and the opportunities and challenges facing China's aging population.
Safe Harbor Statement
This press release contains forward-looking statements. These
statements constitute "forward-looking" statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as
"will,""expects,""anticipates,""future,""intends,""plans,""believes,""estimates,""target,""confident"
and similar statements. Among other things, the Business Outlook
and quotations from management in this announcement, as well as
111's strategic and operational plans, contain forward-looking
statements. 111 may also make written or oral forward-looking
statements in its periodic reports to the U.S. Securities and
Exchange Commission, in its annual report to shareholders, in press
releases and other written materials and in oral statements made by
its officers, directors or employees to third parties. Such
statements are based upon management's current expectations and
current market and operating conditions and relate to events that
involve known or unknown risks, uncertainties and other factors,
all of which are difficult to predict and many of which are beyond
the Company's control. Forward-looking statements involve inherent
risks, uncertainties and other factors that could cause actual
results to differ materially from those contained in any such
statements. Potential risks and uncertainties include, but are not
limited to, uncertainties as to the Company's ability comply with
extensive and evolving regulatory requirements, its ability to
compete effectively in the evolving PRC general health and wellness
market, its ability to manage the growth of its business and
expansion plans, its ability to achieve or maintain profitability
in the future, its ability to control the risks associated with its
pharmaceutical retail and wholesale businesses, and the Company's
ability to meet the standards necessary to maintain listing of its
ADSs on the Nasdaq Global Market, including its ability to cure any
non-compliance with Nasdaq's continued listing criteria. Further
information regarding these and other risks, uncertainties or
factors is included in the Company's filings with the U.S.
Securities and Exchange Commission. All information provided in
this press release is as of the date of this press release, and 111
does not undertake any obligation to update any forward-looking
statement as a result of new information, future events or
otherwise, except as required under applicable law.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
integrated online and offline healthcare platform in China. The Company provides hundreds of
millions of consumers with better access to pharmaceutical products
and medical services directly through its online retail pharmacy
and indirectly through its offline pharmacy network. 111 also
offers online medical services through its Internet hospital, 1
Clinic, which provides consumers with cost-effective and convenient
online consultation and electronic prescription services. In
addition to providing direct services to consumers through its
online retail pharmacy, 111 also enables offline pharmacies to
better serve their customers. The Company's online wholesale
pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to
source a vast selection of pharmaceutical products. The Company's
New Retail platform, by integrating the front and back ends of the
pharmaceutical supply chain, has formed a smart supply chain, which
transforms the flow of pharmaceutical products to pharmacies and
modernizes how they serve their customers.
For more information on 111, please visit
http://ir.111.com.cn/
For more information, please contact:
111, Inc.
Ms. Monica
Mu
IR Director
ir@111.com.cn
Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com
In U.S.
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@ChristensenIR.com
View original
content:http://www.prnewswire.com/news-releases/111-unveils-new-video-on-the-impact-of-the-internet-and-other-new-technologies-on-the-medical-industry-300988863.html
SOURCE 111, Inc.